|Articles|December 21, 2021

Omicron is Now the Dominant Variant in the US, Accounts for 73% of All New Cases

Author(s)Nina Cosdon

Less than 3 weeks after it was first reported, Omicron becomes the dominant COVID-19 variant in the US.

On Monday, the US Centers for Disease Control and Prevention (CDC) estimated that the Omicron variant accounts for 73.2% of new COVID-19 cases in the United States. This report comes just 20 days after Omicron was first detected in the US.

Last week, the CDC reported that Omicron (B.1.1.529) had caused 73.2% of all new cases, with Delta accounting for 12.6%. During the previous week of December 11, Omicron accounted for just 12.6% of new COVID-19 cases, up from 1% the first week of December.

The rapid rise of Omicron overtaking other SARS-CoV-2 strains, including the infectious Alpha and Delta (B.1.617.2) variants, is testament to how the virus can become even more infectious the longer it has to mutate.

According to the World Health Organization (WHO), new Omicron infections are doubling every 1.5-3 days. In certain regions of the US, such as the Pacific Northwest, Great Lakes, Southeast, New England, and states clustered around Texas, Omicron may be responsible for over 90% of cases.

The CDC uses genomic surveillance to identify and track COVID-19 variants. Their system collects and sequences COVID-19 specimens via the National SARS-CoV-2 Strain Surveillance (NS3) program, as well as from CDC-contracted commercial or academic laboratories and state or local public health laboratories.

Though Omicron certainly seems to be more infectious, investigators are still uncertain of whether it is more severe or deadly. The first known Omicron death occurred on Monday in an unvaccinated Texas man in his 50s with underlying health conditions and a prior history of COVID-19 infection.

While Omicron has caused a massive uptick in cases in the US and across the world, infected individuals seem to have less severe disease and hospitalization than previous strains.

Available data suggests Omicron may cause more breakthrough infections, even among people who received a booster vaccine. However, health officials stressed that getting vaccinated is the best way to prevent a wave of Omicron infections from causing further strain on healthcare resources.


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.